Home >> Cardiovascular Devices >> Advertising & Marketing >> Food & Beverage >>

Critical Limb Ischemia Global Clinical Trials Review, H2, 2014

Published: Nov-2014 | Format: PDF | GlobalData | Number of pages: 81 | Code: MRS - 1784

GlobalData's clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, H2, 2014"" provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Critical Limb Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Critical Limb Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Critical Limb Ischemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Critical Limb Ischemia 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Critical Limb Ischemia Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Critical Limb Ischemia 33
Nov 18, 2014: Juventas Therapeutics Presents Phase II Data at AHA Scientific Sessions That Shows JVS-100 is Safe, Potentially Effective in Patients with Critical Limb Ischemia 33
Oct 05, 2014: AnGes Starts Global Phase III Clinical Trials of Collategene for Critical Limb Ischemia 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
AnGes MG, Inc. 35
Clinical Trial Overview of AnGes MG, Inc. 35
ViroMed Co., Ltd. 36
Clinical Trial Overview of ViroMed Co., Ltd. 36
United Therapeutics Corporation 37
Clinical Trial Overview of United Therapeutics Corporation 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
Pluristem Therapeutics Inc. 39
Clinical Trial Overview of Pluristem Therapeutics Inc. 39
TheraVitae Inc. 40
Clinical Trial Overview of TheraVitae Inc. 40
ReNeuron Group plc 41
Clinical Trial Overview of ReNeuron Group plc 41
Intrexon Corporation 42
Clinical Trial Overview of Intrexon Corporation 42
C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43
Aastrom Biosciences, Inc. 44
Clinical Trial Overview of Aastrom Biosciences, Inc. 44
Clinical Trial Overview of Top Institutes / Government 45
Fundacion Progreso y Salud 45
Clinical Trial Overview of Fundacion Progreso y Salud 45
Leiden University Medical Center 46
Clinical Trial Overview of Leiden University Medical Center 46
Tufts University 47
Clinical Trial Overview of Tufts University 47
Northwestern University 48
Clinical Trial Overview of Northwestern University 48
Kansai Rosai Hospital 49
Clinical Trial Overview of Kansai Rosai Hospital 49
Institute of Biomedical Research and Innovation Hospital 50
Clinical Trial Overview of Institute of Biomedical Research and Innovation Hospital 50
Sun Yat-sen University 51
Clinical Trial Overview of Sun Yat-sen University 51
CHU de Reims 52
Clinical Trial Overview of CHU de Reims 52
University of Bern 53
Clinical Trial Overview of University of Bern 53
Kyushu University 54
Clinical Trial Overview of Kyushu University 54
Five Key Clinical Profiles 55

Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables

Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Critical Limb Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Critical Limb Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2014* 35
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2014* 36
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 37
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 38
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2014* 39
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TheraVitae Inc., 2014* 40
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ReNeuron Group plc, 2014* 41
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Intrexon Corporation, 2014* 42
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 43
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2014* 44
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Progreso y Salud, 2014* 45
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 46
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2014* 47
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 48
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Rosai Hospital, 2014* 49
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2014* 50
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 51
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU de Reims, 2014* 52
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bern, 2014* 53
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2014* 54"

List of Figures

Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 80

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing